Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Riess

Showing results (41-50 of 205) with videos related to

Pageof 21
Sort By:
Der Internist|July 1, 1988
[Heparin-induced thrombocytopenia and thrombosis]P Langecker, H Riess, E Hiller, et al.
Thrombosis Research|February 1, 1986
Increased in vitro platelet aggregation in hypertriglyceridemiasH Riess, W Merk, C Falkner, et al.
Deutsche Medizinische Wochenschrift (1946)|October 3, 2013
[Primary pharmacological prevention of thromboembolic events in ambulatory patients with advanced pancreatic cancer treated with chemotherapy?]U Pelzer, M Sinn, J Stieler, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1993
Role of protein S in orthotopic liver transplantationG Himmelreich, R Rosch, P Neuhaus, et al.
Blut|November 1, 1980
Evaluation of hypercoagulability after remission induction chemotherapy of acute leukemiaE Hiller, H Riess, R Hafter, et al.
Klinische Wochenschrift|June 1, 1981
[Nomifensin-induced immune haemolytic anaemias (author's transl)]R Eckstein, H Riess, H Sauer, et al.
Anti-Cancer Drugs|January 6, 2001
The role of gemcitabine alone and in combination in the treatment of pancreatic cancerH Oettle, D Arnold, C Hempel, et al.
Thrombosis Research|August 15, 1984
Effects of BM 13.177, a new antiplatelet drug in patients with atherosclerotic diseaseH Riess, E Hiller, B Reinhardt, et al.
Thrombosis Research|March 1, 1994
Protein S in end stage liver disease and in the course of liver transplantationG Himmelreich, R Rosch, P Neuhaus, et al.
Journal of Thrombosis and Haemostasis : JTH|June 29, 2004
Treatment of patients initially for acute deep vein thrombosis with a low-molecular-weight heparin at a fixed, body weight-independent dosageJ Harenberg, H Riess, J Brom, et al.
Pageof 21

Showing results (41-50 of 205) with videos related to

Sort By:
Pageof 21
Der Internist|July 1, 1988
[Heparin-induced thrombocytopenia and thrombosis]P Langecker, H Riess, E Hiller, et al.
Thrombosis Research|February 1, 1986
Increased in vitro platelet aggregation in hypertriglyceridemiasH Riess, W Merk, C Falkner, et al.
Deutsche Medizinische Wochenschrift (1946)|October 3, 2013
[Primary pharmacological prevention of thromboembolic events in ambulatory patients with advanced pancreatic cancer treated with chemotherapy?]U Pelzer, M Sinn, J Stieler, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1993
Role of protein S in orthotopic liver transplantationG Himmelreich, R Rosch, P Neuhaus, et al.
Blut|November 1, 1980
Evaluation of hypercoagulability after remission induction chemotherapy of acute leukemiaE Hiller, H Riess, R Hafter, et al.
Klinische Wochenschrift|June 1, 1981
[Nomifensin-induced immune haemolytic anaemias (author's transl)]R Eckstein, H Riess, H Sauer, et al.
Anti-Cancer Drugs|January 6, 2001
The role of gemcitabine alone and in combination in the treatment of pancreatic cancerH Oettle, D Arnold, C Hempel, et al.
Thrombosis Research|August 15, 1984
Effects of BM 13.177, a new antiplatelet drug in patients with atherosclerotic diseaseH Riess, E Hiller, B Reinhardt, et al.
Thrombosis Research|March 1, 1994
Protein S in end stage liver disease and in the course of liver transplantationG Himmelreich, R Rosch, P Neuhaus, et al.
Journal of Thrombosis and Haemostasis : JTH|June 29, 2004
Treatment of patients initially for acute deep vein thrombosis with a low-molecular-weight heparin at a fixed, body weight-independent dosageJ Harenberg, H Riess, J Brom, et al.
Pageof 21